https://www.selleckchem.com/products/lee011.html
https://www.selleckchem.com/products/lee011.html
Genome editing in mammalian tissue while using the CRISPR variety I-D nuclease. 38% of the patients had stable disease 100 days. The grade 3 or 4 toxicities that occurred in two or more patients were neutropenia, rash, hyponatremia, and vomiting. The median progression-free survival was 3.1 months (95% CI 1.5-5.6), and the median overall survival was 11.9 months (95% CI 9.0-16.9) in the evaluable study population. GV is well-tolerated in metastatic uveal melanoma. The disease con
Like
Comment
Share
